Management projected strong growth for 2025, driven by expanded reimbursement in key European markets such as Spain and Italy and the expected completion of the post-approval efficacy study (PAES).
Hansa Biopharma reported its Q4 2024 earnings, revealing a larger-than-expected loss and lower-than-forecast revenue. The company posted an EPS of -4.08, significantly missing the forecast of -1.98, ...
Despite the discontinuations, CEO Pascal Soriot said AstraZeneca’s December 2020 acquisition of Alexion was a “fantastic” ...
It’s show-me time for batoclimab, an antibody treatment from Immunovant and Roivant Sciences. Here's what you need to know.
Ford told PEOPLE he was diagnosed with myasthenia gravis in 2022, and was already in the process of losing weight, getting ...
"Slow Ride" singer Colt Ford described how he switched to a healthier lifestyle after he "died twice" from a near-fatal heart ...
Colt Ford says his near-fatal heart attack last April helped kickstart a weight loss journey that's now trimmed him down by ...
Country-rap star Colt Ford got candid with People about his dramatic 60-pound weight loss following a near-fatal heart attack ...
Country-rap star Colt Ford got candid with People about his dramatic 60-pound weight loss following a near-fatal heart attack ...
Country rap star Colt Ford, 55, lost 60 Lbs. after a near-fatal heart attack made him ditch Mountain Dew and fried chicken.
They're also celebrating their 100th anniversary with the annual community-wide campaign, providing funds to local charities ...
Amgen Inc (NASDAQ:AMGN)., a leading biopharmaceutical company with a market capitalization of $155 billion, is at a pivotal juncture as it navigates the competitive landscape of innovative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results